Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Epivax, Inc. patents

List of Epivax, Inc. patents

List of Takeda Pharmaceutical Company patents

List of Pantarhei Bioscience patents

List of Aquacycl patents

List of companies in Apollo Global Management's investment portfolio

List of companies in Whitecap Venture Partners's investment portfolio

Patents where

Current Assignee

Name

is

‌

Epivax, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11045529 Regulatory T cell epitopes, compositions and uses thereof	Patent 11045529 was granted and assigned to Epivax, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	11045529	June 29, 2021
	‌ US Patent 11045532 Regulatory T cell epitopes, compositions and uses thereof	Patent 11045532 was granted and assigned to Epivax, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	11045532	June 29, 2021
	‌ US Patent 10925942 Regulatory T cell epitopes, compositions and uses thereof	Patent 10925942 was granted and assigned to Epivax, Inc. on February, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10925942	February 23, 2021
	‌ US Patent 10980867 Regulatory T cell epitopes, compositions and uses thereof	Patent 10980867 was granted and assigned to Epivax, Inc. on April, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10980867	April 20, 2021
	‌ US Patent 10925940 Regulatory T cell epitopes, compositions and uses thereof	Patent 10925940 was granted and assigned to Epivax, Inc. on February, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10925940	February 23, 2021
	‌ US Patent 11045528 Regulatory T cell epitopes, compositions and uses thereof	Patent 11045528 was granted and assigned to Epivax, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	11045528	June 29, 2021
	‌ US Patent 10213496 Regulatory T cell epitopes, compositions and uses thereof	Patent 10213496 was granted and assigned to Epivax, Inc. on February, 2019 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10213496	February 26, 2019
	‌ US Patent 10925939 Regulatory T cell epitopes, compositions and uses thereof	Patent 10925939 was granted and assigned to Epivax, Inc. on February, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10925939	February 23, 2021
	‌ US Patent 11045530 Regulatory T cell epitopes, compositions and uses thereof	Patent 11045530 was granted and assigned to Epivax, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	11045530	June 29, 2021
	‌ US Patent 10925941 Regulatory T cell epitopes, compositions and uses thereof	Patent 10925941 was granted and assigned to Epivax, Inc. on February, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10925941	February 23, 2021
	‌ US Patent 11045531 Regulatory T cell epitopes, compositions and uses thereof	Patent 11045531 was granted and assigned to Epivax, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	11045531	June 29, 2021
	‌ US Patent 7884184 Regulatory T cell epitopes, compositions and uses thereof	Patent 7884184 was granted and assigned to Epivax, Inc. on February, 2011 by the United States Patent and Trademark Office.		‌ Epivax, Inc.		United States Patent and Trademark Office	7884184	February 8, 2011
	‌ US Patent 10286063 Modified H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence	Patent 10286063 was granted and assigned to Epivax, Inc. on May, 2019 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10286063	May 14, 2019
	‌ US Patent 10751397 Regulatory T cell epitopes, compositions and uses thereof	Patent 10751397 was granted and assigned to Epivax, Inc. on August, 2020 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	10751397	August 25, 2020
	‌ US Patent 11911414 Regulatory T cell epitopes	Patent 11911414 was granted and assigned to Epivax, Inc. on February, 2024 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	11911414	February 27, 2024
	‌ US Patent 12016909 Regulatory T cell epitopes, compositions and uses thereof	Patent 12016909 was granted and assigned to Epivax, Inc. on June, 2024 by the United States Patent and Trademark Office.	‌ Epivax, Inc.	‌ Epivax, Inc.		United States Patent and Trademark Office	12016909	June 25, 2024

16 results

0 selected

16 results

0 selected